Table 1 Baseline characteristics and clinical history of 2137 patients presenting for COVID-19 suspicion
Variable | Total (n = 2137) | Positive SARS CoV2 patients (n = 1148) | Negative SARS CoV2 patients (n = 989) | P Value |
|---|---|---|---|---|
Age, mean ± SD | 45.93 ± 15.34 | 48.60 ± 15.6 | 42.82 ± 14.42 | < 0.001a |
Gender, n (%) | ||||
Female | 1034 (48.3) | 508 (44.2) | 526 (53.1) | < 0.001b |
Male | 1103 (51.6) | 640 (55.7) | 463 (46.8) | |
Vital sings | ||||
Temperature (C°), median (IQR) | 36.4 (36.2) | 36.4 (36.2–36.8) | 36.4 (36.2–36.7) | 0.01c |
Hear rate (bpm), median (IQR) | 90 (78–103) | 94 (82–108) | 87 (75–99) | < 0.001c |
Respiratory rate (bpm), median (IQR) | 22 (20–24) | 22 (20–24) | 22 (20–24) | < 0.001c |
SBP (mmHg), mean ± SD | 191.2 ± 19.1 | 131.3 ± 18.6 | 131.1 ± 19.7 | 0.78a |
DBP (mmHg), mean ± SD | 76.6 ± 20.0 | 76.7 ± 24.4 | 76.5 ± 13.2 | 0.82a |
Oxygen saturation (%), median (IQR) | 94 (90–95) | 93 (85–95) | 95 (93–96) | < 0.001c |
Weight (kg), median (IQR) | 74 (63–85) | 75 (64–86) | 72 (62–84) | < 0.001c |
Height (m), mean ± SD | 1.63 ± 0.09 | 1.62 ± 0.09 | 1.63 ± 0.09 | 0.42a |
BMI (kg/m2), median (IQR) | 27.8 (24.76–31.21) | 28.4 (25.28–31.74) | 27.3 (24.11–30.46) | < 0.001c |
Oxygen saturation < 93%, n (%) | 170 (7.96) | 127 (11.06) | 43 (4.35) | < 0.001 a |
General symptoms, n (%) | ||||
Fever | 891 (41.69) | 615 (53.57) | 276 (27.91) | < 0.001b |
Cough | 1284 (60.08) | 816 (71.08) | 468 (47.32) | < 0.001 b |
Odynophagia | 1058 (49.51) | 574 (50.00) | 484 (48.94) | 0.62 b |
Thoracic pain | 708 (33.13) | 445 (38.76) | 263 (26.59) | < 0.001 b |
Asthenia | 1354 (63.36) | 789 (68.73) | 565 (57.13) | < 0.001 b |
Myalgia | 1188 (55.59) | 705 (61.41) | 483 (48.84) | < 0.001 b |
Rhinorrhea | 652 (30.51) | 373 (32.49) | 279 (28.21) | 0.03 b |
Headache | 1287 (60.22) | 709 (61.76) | 578 (58.44) | 0.11 b |
Anosmia | 410 (19.19) | 309 (26.92) | 101 (10.21) | < 0.001 b |
Conjunctivitis | 304 (14.23) | 162 (14.11) | 142 (14.36) | 0.87 b |
Dyspnea | 788 (36.87) | 550 (47.91) | 238 (24.06) | < 0.001 b |
Comorbidities, n (%) | ||||
COPD | 29 (1.36) | 21 (1.83) | 8 (0.81) | 0.04 b |
Type 2 diabetes mellitus | 326 (15.26) | 218 (18.99) | 108 (10.92) | < 0.001 b |
Hypertension | 447 (20.92) | 285 (24.83) | 162 (16.38) | < 0.001 b |
Chronic Kidney disease | 84 (3.93) | 54 (4.78) | 30 (3.03) | 0.04 b |
Immunodeficiency | 65 (3.04) | 34 (2.96) | 31 (3.13) | 0.81 b |
Hepatopathy | 11 (0.51) | 8 (0.70) | 3 (0.30) | 0.20 b |
Obesity | 1148 (57.72) | 537 (60.47) | 611 (48.92) | < 0.001 b |